Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    October 2017
  1. MOJOLI M, Gersh BJ, Barioli A, Masiero G, et al
    Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Am Heart J. 2017;192:64-75.
    PubMed     Text format     Abstract available


  2. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Am Heart J. 2017;192:57-63.
    PubMed     Text format     Abstract available


    September 2017
  3. GUDNADOTTIR GS, Andersen K, Thrainsdottir IS, James SK, et al
    Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes.
    Am Heart J. 2017;191:65-74.
    PubMed     Text format     Abstract available


    August 2017
  4. PROIETTI M, Airaksinen KEJ, Rubboli A, Schlitt A, et al
    Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
    Am Heart J. 2017;190:86-93.
    PubMed     Text format     Abstract available


  5. PALMERINI T, Serruys P, Kappetein AP, Genereux P, et al
    Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Am Heart J. 2017;190:54-63.
    PubMed     Text format     Abstract available


  6. AUSTIN CO, Landolfo K, Parikh PP, Patel PC, et al
    Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Am Heart J. 2017;190:46-53.
    PubMed     Text format     Abstract available


  7. TUMIN D, Horan J, Shrider EA, Smith SA, et al
    County socioeconomic characteristics and heart transplant outcomes in the United States.
    Am Heart J. 2017;190:104-112.
    PubMed     Text format     Abstract available


    July 2017
  8. ROGERS T, Torguson R, Bastian R, Corso P, et al
    Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.
    Am Heart J. 2017;189:103-109.
    PubMed     Text format     Abstract available


  9. OHUCHI H, Miyazaki A, Negishi J, Hayama Y, et al
    Hemodynamic determinants of mortality after Fontan operation.
    Am Heart J. 2017;189:9-18.
    PubMed     Text format     Abstract available


  10. HOLMES DR, Reddy VY, Buchbinder M, Stein K, et al
    The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial.
    Am Heart J. 2017;189:68-74.
    PubMed     Text format     Abstract available


  11. CUNNINGHAM JW, Nathan AS, Rhodes J, Shafer K, et al
    Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation.
    Am Heart J. 2017;189:184-192.
    PubMed     Text format     Abstract available


  12. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez AF, et al
    Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Am Heart J. 2017;189:146-157.
    PubMed     Text format     Abstract available


    June 2017
  13. BABER U, Sartori S, Aquino M, Kini A, et al
    Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
    Am Heart J. 2017;188:73-81.
    PubMed     Text format     Abstract available


  14. ABNOUSI F, Sundaram V, Yong CM, Prats J, et al
    Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
    Am Heart J. 2017;188:147-155.
    PubMed     Text format     Abstract available


  15. MELINA G, Angeloni E, Refice S, Monti F, et al
    Clinical SYNTAX score predicts outcomes of patients undergoing coronary artery bypass grafting.
    Am Heart J. 2017;188:118-126.
    PubMed     Text format     Abstract available


  16. GOLDBERG DJ, Zak V, Goldstein BH, Chen S, et al
    Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.
    Am Heart J. 2017;188:42-52.
    PubMed     Text format     Abstract available


  17. MOGENSEN UM, Kober L, Kristensen SL, Jhund PS, et al
    The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Am Heart J. 2017;188:35-41.
    PubMed     Text format     Abstract available


  18. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available


  19. DALBY AJ, Gottlieb S, Cyr DD, Magnus Ohman E, et al
    Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
    Am Heart J. 2017;188:156-166.
    PubMed     Text format     Abstract available


  20. HASAN BS, Lunze FI, Alvi N, Shafer KM, et al
    Feasibility of exercise stress echocardiography and myocardial response in patients with repaired congenital heart disease.
    Am Heart J. 2017;188:1-10.
    PubMed     Text format     Abstract available


    May 2017
  21. KONG DF, Saito S, Nakamura S, Mehran R, et al
    Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic cor
    Am Heart J. 2017;187:112-121.
    PubMed     Text format     Abstract available


  22. LEMMERT ME, Oldroyd K, Barragan P, Lesiak M, et al
    Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicent
    Am Heart J. 2017;187:104-111.
    PubMed     Text format     Abstract available


  23. SCIAHBASI A, Rigattieri S, Sarandrea A, Cera M, et al
    Determinants of operator radiation exposure during percutaneous coronary procedures.
    Am Heart J. 2017;187:10-18.
    PubMed     Text format     Abstract available


  24. ARENDT CJ, Hong JH, Daly RC, Scott C, et al
    Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.
    Am Heart J. 2017;187:70-77.
    PubMed     Text format     Abstract available


    April 2017
  25. SMITS PC, Assaf A, Richardt G, Omerovic E, et al
    Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients
    Am Heart J. 2017;186:21-28.
    PubMed     Text format     Abstract available


  26. HANNAN EL, Zhong Y, Jacobs AK, Ling FSK, et al
    Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.
    Am Heart J. 2017;186:118-126.
    PubMed     Text format     Abstract available


  27. EGBE AC, Connolly HM, Khan AR, Niaz T, et al
    Outcomes in adult Fontan patients with atrial tachyarrhythmias.
    Am Heart J. 2017;186:12-20.
    PubMed     Text format     Abstract available


    March 2017
  28. LEE H, Koo BK, Park KW, Shin ES, et al
    A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary arte
    Am Heart J. 2017;185:17-25.
    PubMed     Text format     Abstract available


  29. KLECZYNSKI P, Dziewierz A, Bagienski M, Rzeszutko L, et al
    Impact of frailty on mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;185:52-58.
    PubMed     Text format     Abstract available


  30. BAVISHI C, Sardar P, Chatterjee S, Khan AR, et al
    Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
    Am Heart J. 2017;185:26-34.
    PubMed     Text format     Abstract available


    February 2017
  31. MARTIN GP, Sperrin M, Ludman PF, de Belder MA, et al
    Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;184:97-105.
    PubMed     Text format     Abstract available


  32. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Text format     Abstract available


  33. VOORA D, Coles A, Lee KL, Hoffmann U, et al
    An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
    Am Heart J. 2017;184:133-140.
    PubMed     Text format     Abstract available


    January 2017
  34. RIMAC G, Fearon WF, De Bruyne B, Ikeno F, et al
    Clinical value of post-percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis.
    Am Heart J. 2017;183:1-9.
    PubMed     Text format     Abstract available


  35. EGBE AC, Connolly HM, Niaz T, Yogeswaran V, et al
    Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation.
    Am Heart J. 2017;183:10-17.
    PubMed     Text format     Abstract available


    December 2016
  36. MEHTA RH, Van Diepen S, Meza J, Bokesch P, et al
    Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery
    Am Heart J. 2016;182:62-71.
    PubMed     Text format     Abstract available


  37. BABER U, Dangas G, Cohen DJ, Gibson CM, et al
    Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
    Am Heart J. 2016;182:125-134.
    PubMed     Text format     Abstract available


  38. GRODZINSKY A, Arnold SV, Wang TY, Sharma P, et al
    Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
    Am Heart J. 2016;182:111-118.
    PubMed     Text format     Abstract available


  39. LEE JM, Cho DK, Hahn JY, Song YB, et al
    Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet The
    Am Heart J. 2016;182:1-8.
    PubMed     Text format     Abstract available


  40. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


  41. PRESSLER A, Christle JW, Lechner B, Grabs V, et al
    Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.
    Am Heart J. 2016;182:44-53.
    PubMed     Text format     Abstract available


  42. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Text format     Abstract available


  43. CHAUHAN D, Haik N, Merlo A, Haik BJ, et al
    Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:146-154.
    PubMed     Text format     Abstract available


  44. HARRISON RW, Radhakrishnan V, Lam PS, Allocco DJ, et al
    Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.
    Am Heart J. 2016;182:103-110.
    PubMed     Text format     Abstract available


    November 2016
  45. YAKSH A, Kik C, Knops P, van Ettinger MJ, et al
    Early, de novo atrial fibrillation after coronary artery bypass grafting: Facts and features.
    Am Heart J. 2016;184:62-70.
    PubMed     Text format     Abstract available


  46. PICCARO DE OLIVEIRA P, Gonzales V, Lopes RD, Schmidt MM, et al
    Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention.
    Am Heart J. 2016;181:52-59.
    PubMed     Text format     Abstract available


  47. DERY JP, Mehta SR, Fisher HN, Zhang X, et al
    Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTud
    Am Heart J. 2016;181:26-34.
    PubMed     Text format     Abstract available


    October 2016
  48. WINDECKER S, Tijssen J, Giustino G, Guimaraes AH, et al
    Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Am Heart J. 2016;184:81-87.
    PubMed     Text format     Abstract available


  49. VOLLENBROICH R, Stortecky S, Praz F, Lanz J, et al
    The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2016;184:71-80.
    PubMed     Text format     Abstract available


  50. ALLEN JE, Knight S, McCubrey RO, Bair T, et al
    beta-blocker dosage and outcomes after acute coronary syndrome.
    Am Heart J. 2016;184:26-36.
    PubMed     Text format     Abstract available


  51. SRA S, Tan MK, Mehta SR, Fisher HN, et al
    Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
    Am Heart J. 2016;180:82-9.
    PubMed     Text format     Abstract available


    September 2016
  52. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


  53. TANGUTURI VK, Wasfy JH
    Hospital readmissions after percutaneous coronary intervention aredeclining, but caution ahead is needed.
    Am Heart J. 2016;179:192-4.
    PubMed     Text format    


  54. DE WAHA A, Sandner S, von Scheidt M, Boening A, et al
    A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Inve
    Am Heart J. 2016;179:69-76.
    PubMed     Text format     Abstract available


  55. GILOTRA NA, Bennett MK, Shpigel A, Ahmed HM, et al
    Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.
    Am Heart J. 2016;179:116-26.
    PubMed     Text format     Abstract available


  56. HAO Y, Liu J, Liu J, Smith SC Jr, et al
    Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.
    Am Heart J. 2016;179:107-15.
    PubMed     Text format     Abstract available


    August 2016
  57. DECKER C, Garavalia L, Garavalia B, Gialde E, et al
    Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention.
    Am Heart J. 2016;178:190-7.
    PubMed     Text format     Abstract available


  58. ROTHBERG MB, Martinez KA
    Risky business: Personalizing the approach to percutaneous coronary intervention.
    Am Heart J. 2016;178:185-7.
    PubMed     Text format    


  59. TABBALAT RA, Hamad NM, Alhaddad IA, Hammoudeh A, et al
    Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial.
    Am Heart J. 2016;178:102-7.
    PubMed     Text format     Abstract available


  60. RAO C, Du J, Li X, Li J, et al
    Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Se
    Am Heart J. 2016;178:9-18.
    PubMed     Text format     Abstract available


  61. ARMAGANIJAN LV, Alexander KP, Huang Z, Tricoci P, et al
    Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
    Am Heart J. 2016;178:176-84.
    PubMed     Text format     Abstract available


  62. HARRISON RW, Simon D, Miller AL, de Lemos JA, et al
    Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;178:95-101.
    PubMed     Text format     Abstract available


  63. CAMARO C, Damen SA, Brouwer MA, Kedhi E, et al
    Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
    Am Heart J. 2016;178:37-44.
    PubMed     Text format     Abstract available


  64. KIRAMIJYAN S, Magalhaes MA, Koifman E, Didier R, et al
    Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.
    Am Heart J. 2016;178:19-27.
    PubMed     Text format     Abstract available


    July 2016
  65. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available


  66. TING R, Tejpal A, Finken L, Fisher M, et al
    Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system.
    Am Heart J. 2016;177:145-52.
    PubMed     Text format     Abstract available


  67. ZANGRILLO A, Alvaro G, Pisano A, Guarracino F, et al
    A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Am Heart J. 2016;177:66-73.
    PubMed     Text format     Abstract available


  68. DAYOUB EJ, Nallamothu BK
    Geographic access to transcatheter aortic valve replacement relative to other invasive cardiac services: A statewide analysis.
    Am Heart J. 2016;177:163-70.
    PubMed     Text format     Abstract available


  69. DELGADO-LISTA J, Perez-Martinez P, Garcia-Rios A, Alcala-Diaz JF, et al
    CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat
    Am Heart J. 2016;177:42-50.
    PubMed     Text format     Abstract available


    June 2016
  70. DE LUCA L, Capranzano P, Patti G, Parodi G, et al
    Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations.
    Am Heart J. 2016;176:44-52.
    PubMed     Text format     Abstract available


  71. VAN DER HEIJDEN LC, Kok MM, Danse PW, Schramm AR, et al
    Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
    Am Heart J. 2016;176:28-35.
    PubMed     Text format     Abstract available


  72. ANDERSON LL, Dai D, Miller AL, Roe MT, et al
    Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;176:1-9.
    PubMed     Text format     Abstract available


    May 2016
  73. PARSH J, Seth M, Briguori C, Grossman P, et al
    The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions.
    Am Heart J. 2016;175:160-7.
    PubMed     Text format     Abstract available


  74. DOBSON LE, Fairbairn TA, Musa TA, Uddin A, et al
    Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study.
    Am Heart J. 2016;175:101-11.
    PubMed     Text format     Abstract available


  75. SHIMADA YJ, Cannon CP, Liu Y, Wilson C, et al
    Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care
    Am Heart J. 2016;175:18-27.
    PubMed     Text format     Abstract available


    April 2016
  76. BANOVIC M, Iung B, Bartunek J, Asanin M, et al
    Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
    Am Heart J. 2016;174:147-53.
    PubMed     Text format     Abstract available


  77. ZIMERMAN A, Lopes RD, Stebbins AL, Guimaraes PO, et al
    Pooled analysis of adverse event collection from 4 acute coronary syndrome trials.
    Am Heart J. 2016;174:60-7.
    PubMed     Text format     Abstract available


  78. LIKOSKY DS, Zhang M, Paone G, Collins J, et al
    Impact of institutional culture on rates of transfusions during cardiovascular procedures: The Michigan experience.
    Am Heart J. 2016;174:1-6.
    PubMed     Text format     Abstract available


    March 2016
  79. ESCARCEGA RO, Baker NC, Lipinski MJ, Koifman E, et al
    Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Am Heart J. 2016;173:118-25.
    PubMed     Text format     Abstract available


  80. NIJENHUIS VJ, Bennaghmouch N, Hassell M, Baan J Jr, et al
    Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
    Am Heart J. 2016;173:77-85.
    PubMed     Text format     Abstract available


  81. VASSALLI G, Klersy C, De Servi S, Galatius S, et al
    Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
    Am Heart J. 2016;173:1-7.
    PubMed     Text format     Abstract available


    February 2016
  82. SAIKI H, Sugimoto M, Kuwata S, Kurishima C, et al
    Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease.
    Am Heart J. 2016;172:152-9.
    PubMed     Text format     Abstract available


  83. NYTROEN K, Yardley M, Rolid K, Bjorkelund E, et al
    Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia.
    Am Heart J. 2016;172:96-105.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: